XOMA Royalty’s acquisition of Turnstone Biologics highlights how royalty deals can revive biopharma companies and drive ...

Take a closer look at the radiopharma new wave as Nuclidium and Actithera raise big to develop their platforms.

Discover new treatments like ART-123 advancing toward approval to prevent long-term nerve damage caused by ...

Vienna’s biotech sector soared to €22.7B in 2023, fueling innovation, research, and jobs. Discover what is driving the boom.

The companies Insmed, Cidara Therapeutics, and Cogent Biosciences bagged the biggest biotech funding rounds overall in June ...

I am the Director of Editorial at Labiotech. Born and raised in Western Australia, I earned undergraduate degrees in International Studies and Social Science at the University of South Australia ...

Explore Boston's vibrant biotech landscape with fourteen innovative companies leading the charge in life sciences research.

Antibody therapies constitute a vast global market: currently valued at over $250 billion, the market for antibodies is ...

Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...